Pain Management in Persons with Substance Abuse
|
|
- Lewis Martin
- 6 years ago
- Views:
Transcription
1 Pain Resource Nurse Program Pain Management in Persons with Substance Abuse Joseph R. Ineck, Pharm.D.,CPE Clinical Pain Lead Resource Oral Chemotherapy Nurse Program Program Mountain States Tumor Institute Module 8 St. Luke s Health System 4/11/2015 Copyright Scope of the Problem Misuse, Abuse, Addiction in the United States 10-1
2 Prevalence Rates are Plagued by Terminology Problems No uniform definition of substance abuse DSM-IV-TR definition of substance dependence includes common effects of opioids taken by patients in pain Tolerance and withdrawal Large amounts over a period of time Unsuccessful effort to cut down amount Use of DSM criteria could lead to an apparent increased incidence of substance dependence in persons treated with opioids for pain Critical that nurses know the definitions of terms 8-3 DSM-IV Addiction Definition Substance dependence, or addiction, as defined by the DSM-IV,is indicated by the presence of three or more of the criteria listed below in the last 12 months. Note that all but the first two criteria reflect some form of loss of control over the use of or effects of the drug. Tolerance:Does the patient tend to need more of the drug over time to get the same effect? Withdrawalsymptoms:Does the patient experience withdrawal symptoms when he or she does not use the drug? Continued use of drug despite harm:is the patient experiencing physical or psychological harm from the drug? Loss of control:does the patient take the drug in larger amounts, or for longer than planned? Attempts to cut down:has the patient made a conscious, but unsuccessful, effort to reduce his or her drug use? Salience:Does the patient spend significant time obtaining or thinking about the drug, or recovering from its effects? Reduced involvement:has the patient given up or reduced his or her involvement in social, occupational or recreational activities due to the drug?
3 True Or False If a person goes into withdrawal, they must be addicted. FALSE 8-5 Physical Dependence Definition Physical dependence is a state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and/or administration of an antagonist Normal predictable, physiological response Characterized by drug class specific physical withdrawal syndrome Can develop to opioids within a week Taper the dose to prevent withdrawal Opioid withdrawal symptoms can persist for weeks to months in some persons
4 Tolerance Definition Tolerance is a state of adaptation in which exposure to a drug induces changes that result in diminution of one or more of the drug s effects over time Normal physiological adaptation Tolerance is less predictable than physical dependence and develops more rapidly than analgesia 8-7 Addiction 1,2 A primary, chronic, neurobiologicdisease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry 5 Cs Chronic Compulsive abuse Control is lost Craving Continued abuse despite harm 1 Adapted from: American Academy of Pain Medicine, American pain Society, and American Society of Addiction Medicine. Consensus document Available at: Accessed Savage SR. Assessment for addiction in pain-treatment setting. Clin J Pain. 2002;18:S28-S
5 Addiction A Neurobiological Disease The neurobiology of addiction encompasses more than the neurochemistry of reward There is altered impulse control, altered judgment, and the dysfunctional pursuit of rewards Susceptible individuals may have an alteration of the limbic or related system that causes sensitization to the reinforcing effects of drugs 8-9 Rate Effect PAIN & ANALGESIA CENTER PAG Nucleus Accumbens PLEASURE CENTER Locus Ceruleus Raphe Nucleus Mesolimbic System PAG = periaqueductal gray Nelson RA, et al., Effect of rate of administration on subjective physiological effects of intravenous cocaine in humans. Drug and Alcohol Dependence 82 (2006) McCaffery and Pasero Pain: Clinical Manual p Mosby Inc
6 Addiction: A Multi-factorial Disease State Psychology Environment Availability & Milieu Biology Innate Acquired * Drug Reinforcement * Manifestation of the disease of addiction 8-11 The Pathways of Addiction Persistent Use Addiction Intermittent relapse Abstinence
7 Addiction Behavioral Manifestations A Inability to consistently Abstain B Impairment in Behavioral control C Craving; or increased hunger for drugs or rewarding experiences D Diminished recognition of significant problems with one s behaviors and interpersonal relationships, and E A dysfunctional Emotional response 8-13 Not Addiction! Physical dependence Tolerance Pseudoaddiction
8 Pseudoaddiction Results from the undertreatment of pain Manifested by behaviors similar to addiction Clock watching Focus on obtaining drug Aberrant behaviors Behaviors resolve when the pain is effectively managed 8-15 Definitions 1 Abuse Taking a substance or medicine for non-medical reasons like getting high Experimentation Episodic substance abuse Addiction a neurobiological disease 1 Diversion taken out of legal chain of custody Selling or trading medicines for profit or favors 1 American Pain Society. Definitions related to the use of opioids for the treatment of pain. Available at: Accessed
9 Prevalence of Addiction/Substance Abuse In the General Population In 2013, 21.6 million persons (8.2% of those 12 years or older) were classified with substance dependence or abuse (DSM-IV criteria) Drugs with highest level of abuse were: Marijuana 19.8 million users: 7.5% Pain relievers 4.5 million users: 1.7% Cocaine 1.5 million users: 0.6% Hallucinogens 1.3 million users: 0.5% Inhalants ~500,000 users: 0.2% Heroin ~300,000 users: 0.1% Substance Abuse and Mental Health Services Administration. (2013). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Retrieved October 1,2014, from Addiction A Serious Public Health Problem In treatment United States Population ~ Million Million (11%) Abusers/Addicts needing treatment (alcohol, drugs) 22.7 Million (8%) 1 Orford J. Conceptualizing addiction: addiction as excessive appetite. Addiction. 2001;96: Substance Abuse and Mental Health Services Administration (SAMSHA) National Survey on Drug Use and Health 8-18 Highlights. US Dept of Health & Human Services. Available at: Accessed
10 Prevalence of Addiction/Substance Abuse In Persons Treated with Opioids Reported rates vary depending on definition used and population studied Prevalence does not appear greater than in the general population except in patients with a current or past history of substance abuse or psychiatric co-morbidities 8-19 Recognition Identifying Medication and Substance Abuse 10-10
11 Broaching the Subject 1 1. Biggest initial obstacle to helpful discussion is how to broach the subject and initiate some form of constructive dialogue. 2. General approach is to ask open-ended questions that allow exploration of the person s motivational state without generating significant resistance. Closed questions, likely to evoke resistance: You drink quite a bit, don t you? It seems like you have a problem with marijuana; don t you agree? Don t you think that your cocaine habit is a big cause of this problem? Open-ended questions, to open discussion: Tell me about your drinking in a typical week? What do you enjoy about smoking pot? How does cocaine fit in here? 1 Borrelli B. Using motivational interviewing to promote patient behavior change and enhance health Medscape Available at: Accessed Substance use and abuse Part of the general medical history Non-judgmental, matter-of-fact attitude 1 Start general, get specific How often do you drink alcohol these days? Exaggerating range offers tacit permission to acknowledge heavy use 1 e.g., Do you drink a case or two on a Friday night? How often do you use marijuana or other drugs? Attitudes Why do you drink/use drugs? Do you have health concerns about your alcohol/drug use? 1 Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002; 18 (4Suppl):S28-S
12 Assessment: Interview Tips **Be nonjudgmental** Explain importance of information Feelings of impending withdrawal does drug use helps relieve pain or other problems Be aware of stages of change problems or side effects Use established assessment tools 8-23 Track marks and skin-popping scars Skin-popping scar Track marks
13 Intermediate Skin Popping Scar Intermediate scar 8-25 Skin Abscess on Neck Abscess
14 Perforated Septum (View into Left Nostril) Right turbinates Left turbinates Ulceration 8-27 Constricted Pupil
15 Screening Assessment Tools CAGE-AID Two-Item Conjoint Screening (TICS) for Alcohol & Other Drug Problems Drug Abuse Screen Test (DAST): 28 or 10 items Screener and Opioid Assessment for Patients in Pain (SOAPP) The Opioid Risk Tool (ORT) 8-29 Pain Management Guidelines for Patients with the Disease of Addiction Team approach with case conferences Set realistic goals Treat depression and comorbid psychiatric problems If possible, treat the cause of the pain Try nondrug methods of pain control Maximize nonopioids and adjuvants Choose long-acting opioids when possible Minimize short-acting PRN doses if possible Consider tolerance - patients with abuse history usually require higher doses
16 A Multidisciplinary Team Physician Nurse Addiction Specialist Patient Psychologist/ Counselor Sponsor Social Worker Pharmacist 8-31 Pharmacist Role Collaborate with other health care team members Assess for the presence of pain/addiction and related symptoms such as anxiety and depression Assess, document, and report aberrant behaviors Advocate for effective pain management Provide ongoing communication with the family
17 Challenges to Pharmacist Behaviors that seem manipulative Favoring one provider over another Complimenting specific persons who respond to requests Exhibiting anger when needs are unmet Requesting IV medications be given fast CONSISTENCY is the key to working with this population..be CAREFUL about making exceptions 8-33 Assess and Document Outcomes of Opioid Therapy Analgesia Pain relief Activities of Daily Living Physical, social and emotional function Adverse Events Side effects or other adverse events Aberrant Drug-Related Behaviors Behaviors suggestive of addiction
18 Analgesia Goal is to provide pain relief Increased comfort should improve the patient s quality of life Perform and document routine pain assessments: Average pain during the past week (0-10) Worst pain during the past week (0-10) % of pain relief in the past week 8-35 Activities of Daily Living Goal is to increase activities of daily living Pain relief should improve function Conduct a routine functional assessment: Physical functioning Mood Sleep Relationships Family and Social Networks Overall
19 Adverse Events Goal is to minimize adverse events Adverse events could affect adherence Conduct a routine assessment of side effects: GI: Constipation, nausea, vomiting CNS: Mental clouding, drowsiness, fatigue Other: Itching 8-37 Aberrant Drug-Related Behaviors Goal is to detect aberrant drug-related behaviors early on to prevent abuse, diversion and protect the practice of pain management Consider Cultural norms Less predictive behaviors More predictive behaviors
20 Aberrant Behaviors: Cultural Norms? Borrowing drugs from family and friends Hoarding drugs With improvement of symptoms With resolution of the problem 8-39 Less Predictive Aberrant Behaviors Drug hoarding when symptoms are improved Acquiring drugs from multiple medical sources Aggressive demands for a higher dose Unapproved use of a drug to treat a symptom, e.g., use of an opioid to treat anxiety Unsanctioned dose escalation (1-2x) Reporting psychic effects Requesting specific drugs
21 More Predictive Aberrant Behaviors Selling prescription drugs Forgery of prescriptions Concurrent illicit drug use Multiple prescription/medication losses Ongoing unsanctioned dose escalations Stealing and borrowing drugs Obtaining prescription drugs from nonmedical sources Non-sanctioned route of administration Repeated resistance to change inflexibility 8-41 Causes of Aberrant Behaviors Addiction or pseudoaddiction? Psychiatric disease Personality disorder Depression, anxiety Organic encephalopathy Situational stressors Chemical coping Criminal intent
22 Risk Factors for Addiction/Substance Abuse Family history of substance abuse Legal problems Personal drug or alcohol abuse Mental health problems Multiple motor vehicle accidents Cigarette smoking Reporting fewer side effects High opioid dose 8-43 Opioid Agreements Written documents signed by both clinician and patient Spell out expected behaviors and consequences of these behaviors Purpose is to promote safe and effective use of controlled substances Provide informed consent on risks and benefits of long-term opioid therapy
23 Dispensing Issues One provider One pharmacy Limit the amount of medication given at any one time Weekly or 2-3 day prescriptions Utilize pill counts Assess for independent dose escalation and shortages 8-45 Urine Drug Screens Purposes Screen for illicit drugs Screen for controlled substances not prescribed Verification that patient is taking and not diverting prescribed drug Understand the limitations False positives Detection limits vary Ongoing testing needed for verification
24 12 Step Programs Programs Alcoholics Anonymous Narcotics Anonymous Can assist in the pain management plan Curtail drug abuse Minimize aberrant behaviors Attendance should be documented Difference in goals may preclude participation Drug-free versus using opioids for pain 8-47 Opioid Treatment of Patients with the Disease of Addiction Understand tolerance may be present Clear communications between staff and patient and family Avoid parenteral opioids if possible Avoid short-acting PRN formulations When possible, use long-acting opioids Combine opioids with nonopioids and use other multimodal therapies
25 Long-term Care and Follow-up Low risk patient Minimally monitored therapy Psychiatric diagnosis/altered coping Structure and psychiatric input Addiction Highest structure Urine toxicology Recovery programs Nursing role in long-term follow-up Telephone triage Patient follow-up visits 8-49 Addiction Maintenance Therapy Methadone and buprenorphine are used in addiction maintenance programs to prevent craving Methadone maintenance therapy can only be provided by Opioid Treatment Programs certified by the federal government Buprenorphine is approved for in-office treatment of opioid dependence
26 Barriers to Pain Relief Related to Addiction Healthcare professionals may underprescribe Lack of knowledge about addiction, tolerance, and physical dependence Fear of scrutiny by regulatory agencies Patients and Families Patients may be reluctant to take opioids because of fears and confusion about addiction Families may withhold analgesics from patients Healthcare Systems 8-51 Principles of Pain Management in Patients with Substance Abuse Inadequate knowledge and fear of addiction hinder pain management in all patient populations Diagnosis requires ongoing assessment of aberrant behaviors along a continuum Goals of pain management include improving analgesia and activities of daily living, and controlling adverse events and aberrant behaviors Pain management requires effective communication and a multimodal approach including drug and nondrug strategies Patients with an addictive disease present unique challenges but deserve appropriate pain management
27 Case Study Mr. Schmidt is a 28-year old man who is admitted to the ICU following a motor vehicle accident. Injuries include a broken mandible, a crushed pelvis, and fractured ribs. His blood level on admission to the ED was Urine toxicology revealed the presence of cannabinoids. He has a history of polysubstance abuse; he started drinking alcohol heavily in high school and also experimented with amphetamines. His mother and sister report that he straightened out after graduation and has been working at an auto repair shop Pain Management in the ICU Case Continued Pain is managed with a morphine drip in the ICU Pain consistently rated high 10/10 in the pelvis 8/10 ribs Staff reports that patient is on the light every hour requesting a bolus of IV morphine Patient is sleeping a lot and does not appear to be in pain Patient requests morphine be given faster for better efficacy
28 Addiction Issues Case Continued How to assess and treat pain in patients with a current or past history of abuse Consideration of tolerance issues Risk of withdrawal from a variety of substances Behavioral assessment and management (? active addiction or pseudoaddiction) 8-55 Pain Management in Rehab Case Continued Out of ICU admitted to orthopedic trauma unit Pain management regimen Morphine ER 30 mg every 8 hours Morphine sulfate short-acting mg every 3 hours as needed for pain flares Celecoxib 200 mg per day Gabapentin 3600 mg per day Pain rating 7 on a 0-10 scale Requests PRN morphine every 3 hours Friends visit frequently his behavior changes Nursing staff requests a collaborative team meeting
29 Discharge to Home Case Conclusion Patient is discharged from the hospital Continues to be on opioids for pain control Referrals Counseling Alcoholics Anonymous Chronic pain support group Outpatient rehabilitation Counseled to keep his medications in a secure location
Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals
Anne F. Walsh, MSN, ANP BC, ACHPN, CWOCN Kathleen Broglio, MN, ANP BC, ACHPN, CPE Disclosures Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals
More informationAppendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
More informationRule Governing the Prescribing of Opioids for Pain
Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This
More informationAddressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain
Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Ajay D. Wasan, MD, MSc Professor of Anesthesiology and Psychiatry Vice Chair for Pain Medicine, Department of Anesthesiology University
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationColorado State Board of Medical Examiners Policy
POLICY NUMBER: 10-14 Title: Guidelines for the Use of Controlled Substances for the Treatment of Pain Date Issued: May 16, 1996 Date(s) Revised: November 18, 2004 Reference: 12-36-117, C.R.S. Purpose:
More informationDisclosures. The Problem. The Problem. The Problem. The Problem. Buprenorphine Use in Combined Chronic Pain and Opioid Addiction
Buprenorphine Use in Combined Chronic Pain and Opioid Addiction Sandra D. Comer, Ph.D. Disclosures Within the last 3 years, consulted for AstraZeneca, BioDelivery Sciences, Camarus, Clinilabs, Grunenthal,
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationUniversal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?
Learning objectives 1. Identify the contribution of psychosocial and spiritual factors to pain 2. Incorporate strategies for identifying and mitigating opioid misuse 3. Incorporate non-pharmaceutical modalities
More informationChronic Pain, Opioids, & Addiction: Assessing and Managing Risk
Chronic Pain, Opioids, & Addiction: Assessing and Managing Risk Randy Brown MD, PhD, FASAM Associate Professor, Dept of Family Medicine Director, Center for Addictive Disorders, UWHC Director, UW Addiction
More informationMEDICATION MANAGEMENT AGREEMENT
MEDICATION MANAGEMENT AGREEMENT The goal of this agreement is to ensure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. The
More informationFY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
More informationOpioid Analgesics: Responsible Prescribing in the Midst of an Epidemic
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Lucas Buffaloe, MD Associate Professor of Clinical Family and Community Medicine University of Missouri Health Care Goals for today
More informationProposed Revision to Med (i)
Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and
More informationPerinatal, Neonatal, Pediatric Conference
Perinatal, Neonatal, Pediatric Conference Presented By: Cheryl Piper, R.N., CADC Vice-President of Clinical Services Remedies Renewing Lives Objectives Learn about drug trends in Illinois/Winnebago County
More informationOPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse
OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse Advances in pharmacologic therapy have improved quality of life for patients living with pain, ADHD, and other conditions.
More informationTaking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on Long-term Opioid Therapy for Chronic Pain
Taking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on Long-term Opioid Therapy for Chronic Pain Department of Veterans Affairs (VA) and Department of Defense
More informationTreatment Team Approaches in Substance Abuse Treatment
Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:
More informationAlcohol and Other Drug Service Definitions
Table of Contents OAC 3793:2-1-08 Treatment services (E) Consultation... 2 (F) Referral and information service... 2 (G) Intervention service... 2 (H) Hotline service... 2 (I) Training service (non-prevention)...
More informationMental Health Nursing: Substance-Related Disorders. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Substance-Related Disorders By Mary B. Knutson, RN, MS, FCP History of Psychoactive Substances Used by people in almost all cultures since prehistoric times Produce effects in the
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationOPIOIDS AND NON-CANCER PAIN
Ch05.qxd 1/6/04 4:33 PM Page 77 CHAPTER 5 OPIOIDS AND NON-CANCER PAIN Background 78 Side-effects of opioids 78 Tolerance, physical dependence and addiction 79 Opioid-induced pain 79 Practical issues 80
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationReadopt with amendment Med 502, effective (Document #11090), to read as follows:
Adopted Rules 11-2-16 1 Readopt with amendment Med 502, effective 5-3-16 (Document #11090), to read as follows: PART Med 502 OPIOID PRESCRIBING Med 502.01 Applicability. This part shall apply to the prescribing
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationPrescription Opioid Addiction
CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett
More informationINFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine
INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine The purpose of this agreement is to give you information about the medications you will be taking for
More informationThe 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):
Smoking Cessation Module Tobacco use is the single greatest preventable cause of chronic diseases and premature deaths worldwide. The Canadian Cancer Society reports that tobacco product use is responsible
More informationMissouri Guidelines for the Use of Controlled Substances for the Treatment of Pain
Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationPain, Opioids, & Substance Use Disorders
Pain, Opioids, & Substance Use Disorders Kenny Jackson, PharmD, CPE Professor & Senior Associate Dean for Academic Affairs College of Pharmacy Larkin University Miami, Florida Editor-in-Chief Journal of
More informationPain Management and Addiction: Clinical Challenges
Pain Management and Addiction: Clinical Challenges MMS Pain Management Forum March 12, 2010 Associate Professor of Medicine Boston University School of Medicine Boston Medical Center Conflicts of Interest
More informationTHE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at sandymorgenthal@yahoo.com
More informationPatient Application for Treatment
Address: 179 Linwood Ave. Colchester, CT 06415 Phone: (860) 603-3541 Fax: (860) 603-3544 Visit Date: / / MR#: Patient Application for Treatment 1. Name: 2. Date of Birth: 3. Social Security #: 2. Address:
More informationFor female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials:
Which doctor are you here to see? NAME OF PATIENT: DATE: TO THE PATIENT: As a patient, you have the right to be informed about your condition and the recommended medical or diagnostic procedure or drug
More informationMethadone Maintenance 101
Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationNORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
More informationRisk Reduction Strategies in Pain Management
Risk Reduction Strategies in Pain Management Melissa J. Durham, PharmD, MACM, BCACP, DAAPM Assistant Professor of Clinical Pharmacy USC School of Pharmacy Clinical Pharmacist, The USC Pain Center Learning
More informationResponding to The Joint Commission Alert on Safe Use of Opioids in Hospitals
Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management The Johns Hopkins Hospital Objectives and Disclosures
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationTrigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!
More informationFLAME TEEN HANDOUT Week 9 - Addiction
FLAME TEEN HANDOUT Week 9 - Addiction Notes from the large group presentation: What was your overall reaction of the presentation? What did the presenter say about addition? What did you agree with? Was
More informationDrug Use and Young People. Long Island Council on Alcoholism and Drug Dependence, Inc. LICADD
Drug Use and Young People Long Island Council on Alcoholism and Drug Dependence, Inc. LICADD 516-747-2606 631-979-1700 1-800-585-5422 www.licadd.org Not necessarily a new problem, nor unique to Long Island.
More informationPractical Pain Assessment- Screening for Psychosocial Risk. Session #3 Roman D. Jovey, MD
Practical Pain Assessment- Screening for Psychosocial Risk Session #3 Roman D. Jovey, MD Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationWhat do they have in common?
What do they have in common? Opioid use in USA Approximately 9 million people on long term opioids Approximated 5 million people reporting non-medical use of opioids 1997: 96mg/person morphine eq dispensed
More informationOPIOID PAIN MEDICATION Agreement and Informed Consent
OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The
More informationThe Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016
The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of
More informationClinical Evaluation: Assessment Goals
Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationPatient and Family Agreement on Opioids
Patient and Family Agreement on Opioids We care about our patients and are committed to their recovery and wellness. We offer our patients medications and options for various services to keep them from
More informationModule II Opioids 101 Opiate Opioid
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!
More informationASPMN Conference Baltimore, Maryland
ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationSubstance use and addictive disorders in Palliative care
Substance use and addictive disorders in Palliative care Dr. Maureen Allen BN, CCFP-EM(PC) Chronic Pain and Palliative Care Assistant Professor Dalhousie University September 22, 2017 No Disclosures SB:
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationFoundations of Safe and Effective Pain Management
Foundations of Safe and Effective Pain Management Evidence-based Education for Nurses, 2018 Module 1: The Multi-dimensional Nature of Pain Module 2: Pain Assessment and Documentation Module 3: Management
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationSubject: Pain Management (Page 1 of 7)
Subject: Pain Management (Page 1 of 7) Objectives: Managing pain and restoring function are basic goals in helping a patient with chronic non-cancer pain. Federal and state guidelines require that all
More informationOpioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM
Western Occupational Health Conference September 14, 2012 Opioid - Use & Misuse Scott Levy, MD MPH FACOEM Steven Feinberg, MD, MPH Disclosure Information Western Occupational Health Conference 2012 Steven
More informationSOCI221. Session 11. Crisis and Trauma Issues: Alcohol and other drugs; Eating disorders and Referrals. Department of Social Science
SOCI221 Session 11 Crisis and Trauma Issues: Alcohol and other drugs; Eating disorders and Referrals Department of Social Science Endeavour College of Natural Health endeavour.edu.au 1 Session Aim The
More informationH NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.
H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been
More informationPatient Agreement for the use of Opioid Medications
today s date Patient Name date of birth Patient Agreement for the use of Opioid Medications The purpose of this agreement is to give you information about the medications that may be part of your treatment
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners, Albany, NY Assistant Professor of Medicine,
More informationKANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998
KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble
More informationIDDT Fidelity Action Planning Guidelines
1a. Multidisciplinary Team IDDT Fidelity Action Planning Guidelines Definition: All clients targeted for IDDT receive care from a multidisciplinary team. A multi-disciplinary team consists of, in addition
More information7/7/2016 Journal of the American Medical Association,
1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of
More informationThe Impaired Professional. Peter Cohen, D.O.
The Impaired Professional Peter Cohen, D.O. Definition The American Medical Association (AMA) defines impairment as the inability to practice medicine with reasonable skill and safety to patients by reason
More informationMedication Agreements Promoting awareness, dialogue and level-set expectations
Medication Agreements Promoting awareness, dialogue and level-set expectations A young man had his leg amputated following a work-related injury. His pain doctor, by all accounts, was trying to responsibly
More informationWelcome to the Opioid Overdose Prevention Project
Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize
More informationScreener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R)
Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) The Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) is a tool for clinicians to help determine how much
More informationJohn Murphy DO, MS Lynx Healthcare
Addiction to Pain Medication and Treatment John Murphy DO, MS Lynx Healthcare No Disclosures Objectives 1 Understand basic neurobiology and learning theory around opioid addiction 2 Identify aberrant behavior
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More informationPain and Addiction. Edward Jouney, DO Department of Psychiatry
Pain and Addiction Edward Jouney, DO Department of Psychiatry Case 43 year-old female with a history chronic lower back pain presents to your clinic ongoing care. She has experienced pain difficulties
More informationSubstance Use Disorders in Primary Care
Substance Use Disorders in Primary Care Jin Hee Yoon-Hudman, MD Assistant Vice President, Medical Director, Behavioral Health Healthfirst Fall Symposium Prevention as a Priority in Value-Based Healthcare,
More informationSUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program
SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets Risk Evaluation and Mitigation Strategy (REMS) Program Office-Based Buprenorphine Therapy for Opioid Dependence: Important Information for Prescribers
More informationRevised 9/30/2016. Primary Care Provider Pain Management Toolkit
Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral
More informationSUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
More information11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dean Drosnes, MD, FASAM Associate Medical Director Caron Treatment Centers ASAM Disclosure of Relevant Financial Relationships Date of Activity: Nov 3, 2016 Name Commercial Interests Relevant Financial
More informationControlled Substance and Wellness Agreement
Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)
More informationMedication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior
Medication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior Ernest J Dole, PharmD, PhC, FASHP, BCPS, CDE Pharmaceutical Care Coordinator ABQ Health
More informationSUBSTANCE ABUSE PATIENT
PREVENTION IN THE SUBSTANCE ABUSE PATIENT Valerie Carrejo, MD UNM Family and Community Medicine DISCLOSURES NONE OBJECTIVES Identify the importance of addressing substance abuse in the primary care setting
More informationNurse Practitioner Practice Guideline Treatment Agreements
Nurse Practitioner Practice Guideline Treatment Agreements In November 2012, the New Classes of Practitioners Regulations (NCPR) under Canada s Controlled Drug and Substances Act (CDSA) came into force,
More informationASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service
1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 0 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 1 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 2 The patient
More informationPharmacist s Role In Pain Management. Katrina Lynn, Pharm D PSHP Annual Assembly: October 12, 2017
Pharmacist s Role In Pain Management Katrina Lynn, Pharm D PSHP Annual Assembly: October 12, 2017 1 Presentation Objectives Briefly discuss Geisinger Health System and the use of Pain Management Pharmacists
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationAddiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017
Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction
More informationChronic Pain Management in the Primary Care Setting
Chronic Pain Management in the Primary Care Setting Keeping you and your patients safe. Joel Porter, MD October 1, 2015 Chronic Pain Management Chronic pain is a major public health problem Existing chronic
More informationPOLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER
More informationSubstance Abuse Protracted Withdrawal
Substance Abuse Protracted Withdrawal Overview 1. Acute and Protracted Withdrawal 2. Withdrawal Potential Kate Speck, PhD, MAC, LADC 3. Recovery Reinforcers 1 2 3 Addiction Addiction is a primary, chronic,
More informationTobacco, alcohol, and opioid dependence
Tobacco, alcohol, and opioid dependence Sheila Duffy Chief Executive, ASH Scotland RCP Addictions Faculty meeting, Dunkeld 27 th February 2015 Alcohol and drugs in Scotland headline stats there were 1,100
More informationClinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationAlberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007
Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there
More informationSUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic
SUBSTANCE ABUSE IN THE ELDERLY The Invisible Epidemic IS IT POSSIBLE TO TEACH AN OLD DOG NEW TRICKS? GUIDELINES All forms of addiction know no age limit. Don t blame all problems on aging. Few realize
More informationOpioids in the Management of Chronic Pain: An Overview
Opioids in the Management of Chronic Pain: An Overview Appropriate treatment of chronic pain may include both pharmacologic and non-pharmacologic modalities. The Board realizes that controlled substances,
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with
More information